Poly Medicure Share Price | Poly Medicure Stock Screener
POLYMED
Medical Equipment
Share Price NSE
₹1677.80
▼
-54.50 (-3.15%)
Share Price BSE
₹1680.05
▼
-57.75 (-3.32%)
As of July 3, 2026, the Poly Medicure share price (NSE: POLYMED) is ₹1,677.80 on NSE and ₹1,680.05 on BSE, down 3.15% from the previous close, with shares trading between ₹1,665.00 and ₹1,777.00, and a 52-week range of ₹1,191.10–₹2,224.30.
Analyse Poly Medicure stock price data download and track historical price performance.
Use the Poly Medicure stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Poly Medicure Market Cap
₹16,750.67 Cr.
POLYMED P/E Ratio (TTM)
52.16
Poly Medicure P/B Ratio
5.39
EPS (TTM)
₹31.79
Dividend Yield
0.21%
Debt to Equity
0.08
POLYMED 52 Week High
₹2224.30
Poly Medicure 52 Week Low
₹1191.10
Operating Margin
21.00%
Profit Margin
11.73%
POLYMED Revenue (TTM)
₹554.00
EBITDA
₹130.00
Net Income
₹65.00
Total Assets
₹3,919.00
Total Equity
₹3,106.00
Poly Medicure Share Price Chart
Screen Poly Medicure share price with an interactive chart. Analyse POLYMED price trends and volatility across different timeframes.
Poly Medicure Company Profile - Fundamental Screener
Screen Poly Medicure company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for POLYMED shares.
Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
Chairperson/CEO
Devendra Raj Mehta
ISIN
INE205C01021
Website
https://www.polymedicure.com
Poly Medicure Balance Sheet Screener
Screen POLYMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,919 | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 |
| Current Assets | 1,942 | 1,917 | 842 | 807 | 783 | 704 | 318 | 302 | 255 | 205 |
| Fixed Assets | 1,519 | 1,084 | 867 | 635 | 488 | 426 | 363 | 306 | 265 | 207 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 194 | 57 | 37 | 42 | 63 | 87 | 135 | 119 | 104 | 72 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3,106 | 2,766 | 1,470 | 1,242 | 1,088 | 966 | 435 | 381 | 338 | 272 |
| Share Capital | 51 | 51 | 48 | 48 | 48 | 48 | 44 | 44 | 44 | 44 |
| Reserves & Surplus | 3,056 | 2,715 | 1,422 | 1,194 | 1,040 | 918 | 391 | 337 | 294 | 227 |
Poly Medicure Income Statement Screener - Profit & Revenue Analysis
Screen Poly Medicure income statement and profit fundamentals.
Analyze POLYMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Poly Medicure share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 554 | 467 | 447 | 479 | 522 | 393 | 402 | 447 | 448 | 316 | 335 | 352 | 357 | 266 | 254 |
| Expenses | 424 | 321 | 298 | 329 | 389 | 282 | 281 | 305 | 310 | 224 | 234 | 253 | 249 | 202 | 202 |
| EBITDA | 130 | 146 | 149 | 150 | 132 | 112 | 121 | 142 | 138 | 92 | 101 | 99 | 108 | 64 | 51 |
| Operating Profit % | 21.00% | 27.00% | 26.00% | 26.00% | 21.00% | 26.00% | 27.00% | 27.00% | 27.00% | 27.00% | 27.00% | 25.00% | 27.00% | 22.00% | 19.00% |
| Depreciation | 38 | 21 | 23 | 25 | 29 | 16 | 20 | 21 | 21 | 15 | 16 | 16 | 16 | 14 | 14 |
| Interest | 6 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 4 | 2 | 1 |
| Profit Before Tax | 85 | 123 | 123 | 122 | 98 | 93 | 99 | 118 | 113 | 75 | 83 | 81 | 88 | 49 | 36 |
| Tax | 20 | 31 | 30 | 30 | 27 | 24 | 24 | 31 | 28 | 16 | 20 | 19 | 23 | 13 | 9 |
| Net Profit | 65 | 92 | 93 | 92 | 71 | 68 | 74 | 87 | 85 | 59 | 63 | 62 | 65 | 36 | 27 |
| EPS | 6.54 | 8.92 | 9.19 | 9.06 | 7.00 | 7.12 | 7.71 | 9.01 | 8.48 | 6.13 | 6.54 | 6.48 | 6.78 | 3.77 | 2.81 |
Poly Medicure Cash Flow Screener - Liquidity Fundamentals
Screen POLYMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 240 | 266 | 191 | 124 | 119 | 131 | 107 | 75 | 56 | 63 |
| Investing Activities | -1,194 | -241 | -179 | -85 | -436 | -110 | -101 | -88 | -56 | -31 |
| Financing Activities | 951 | -20 | -13 | -35 | 317 | -21 | -5 | 16 | 0 | -31 |
| Net Cash Flow | -3 | 5 | -1 | 3 | 0 | 1 | 1 | 3 | 0 | 1 |
Poly Medicure Shareholding Pattern Screener
See Poly Medicure shareholding pattern with promoter, FII, and DII holdings.
Check Poly Medicure promoter holding and ownership changes for POLYMED on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.42% | 62.44% | 62.44% | 62.42% | 62.42% | 53.15% | 66.03% | 62.56% |
| FII Holding | 5.91% | 11.46% | 11.41% | 9.77% | 9.40% | 12.38% | 9.91% | 11.10% |
| DII Holding | 15.59% | 11.96% | 11.72% | 13.54% | 13.84% | 7.22% | 9.35% | 12.48% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.61% | 11.08% | 11.37% | 11.25% | 11.30% | 11.34% | 11.37% | 10.70% |
| Other Holding | 3.47% | 3.07% | 3.07% | 3.02% | 3.04% | 15.92% | 3.36% | 3.16% |
| Shareholder Count | 73,414 | 65,583 | 71,142 | 64,400 | 67,750 | 36,712 | 36,852 | 40,516 |
Poly Medicure Share Dividend Screener - Share Yield Analysis
Check Poly Medicure dividend history with payout and yield data.
View Poly Medicure dividend details including ex-dates and amounts for POLYMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹3.50 | 0.29% |
| 2024-March | ₹3.00 | 0.13% |
| 2023-March | ₹3.00 | 0.19% |
| 2022-March | ₹2.50 | 0.27% |
| 2021-March | ₹2.50 | 0.26% |
| 2020-March | ₹2.00 | 0.24% |
| 2019-March | ₹2.00 | 0.86% |
| 2018-March | ₹2.00 | 0.91% |
| 2017-March | ₹2.50 | 1.00% |
Poly Medicure Stock Index Membership
See which indices include Poly Medicure stock.
Check POLYMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MOMENTUM 50
NIFTY500 MULTICAP
NIFTY500 MULTICAP MOMENTUM QUALITY 50
NIFTY500 SHARIAH
Poly Medicure Market Events Screener - Corporate Actions
Get Poly Medicure corporate actions including splits, bonuses, and buybacks.
Check Poly Medicure stock events that may affect POLYMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.50 /share | -22.75% | ||
| Dividend | ₹ 2.50 /share | -15.72% | ||
| Dividend | ₹ 2.50 /share | 30.39% | ||
| Dividend | ₹ 3.00 /share | 44.66% | ||
| Dividend | ₹ 3.00 /share | 48.83% | ||
| Annual General Meeting | NA | -7.22% | ||
| Annual General Meeting | NA | -4.14% | ||
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | -0.03% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 0.14% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -4.08% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -6.11% |
| 2025-05-06 | 2025-05-06 | Quarterly Result Announcement | NA | -0.13% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -0.46% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 2.58% |
| 2017-03-24 | 2017-03-28 | Bonus | 1:1 | - |
Poly Medicure Competitors Screener - Peer Comparison
Screen POLYMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 16,751 | 52.16 | 1,875 | 6.61% | 326 | 64.08 |
| Tarsons Products | 1,384 | 96.64 | 423 | 3.45% | 16 | 63.43 |
| Q-Line Biotech | 1,278 | 22.88 | 342 | 5.93% | 56 | 60.26 |
| Laxmi Dental | 1,231 | 42.74 | 272 | 12.00% | 22 | 51.64 |
| Osel Devices | 807 | 28.37 | 293 | 56.84% | 30 | 42.30 |
| Fabtech Technologies | 696 | 18.16 | 411 | 22.29% | 36 | 54.23 |
| Vasa Denticity | 657 | 65.39 | 279 | 10.97% | 10 | 42.93 |
| Hemant Surgical Industries | 518 | 29.66 | 232 | 107.34% | 19 | 42.65 |
| Prevest Denpro | 448 | 22.31 | 72 | 7.02% | 21 | 40.76 |
| Aprameya Engineering | 286 | 56.13 | 55 | -59.83% | 5 | 35.37 |
Poly Medicure Company Announcements - News Screener
Screen POLYMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Closure of Trading Window | - | |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-06-29 | Poly Medicure Limited Has Informed The Exchange About The Re-Schedule Of Investor/Analyst Meet | - |
| 2026-06-28 | Intimation For The Schedule Of Investor/Analyst Call/Meet | - |
| 2026-06-18 | Intimation For The Schedule Of Investors/Analysts Call/Meet | - |
| 2026-06-16 | The Company Is In Receipt Of An Order Passed By Office Of Divisional Commissioner Government Of The NCT Of Delhi Revenue Department: Stamp & Registration Branch Through The Collector Of Stamps | - |
| 2026-06-12 | Intimation Of Investor/Analyst Meet | - |
| 2026-06-10 | Investors/Analysts Meet Schedule | - |
| 2026-06-03 | Intimation Of Analyst/Investor Meet | - |
| 2026-06-02 | Intimation For The Analyst/Investors Meet | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-26 | Investors Call Scheduled To Be Held On 27 May 2026 Is Cancelled - Updates On Call | - |
| 2026-05-26 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-25 | Declaration Of Unmodified Opinion On The Audited Financial Results(Standalone & Consolidated) For The Quarter And Year Ended For The 31St March 2026 | - |
| 2026-05-25 | Statement Of Deviation & Variation For The Quarter Ended On 31St March 2026 | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-25 | Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2026 | - |